BMJ  1989;298:1552-1556 (10 June), doi:10.1136/bmj.298.6687.1552

Relation between mortality and treated blood pressure in elderly patients with hypertension: report of the European Working Party on High Blood Pressure in the Elderly.

Klinisch Laboratorium Hypertensie, University Hospital Gathuisberg, Leuven, Belgium.

OBJECTIVE--To investigate the relation between mortality and treated systolic and diastolic blood pressures. DESIGN--Randomised double blind placebo controlled trial. Mortality in the two treatment groups was examined in thirds of treated systolic and diastolic blood pressures. PATIENTS--339 And 352 patients allocated to placebo and active treatment, respectively. The groups were similar at randomisation in sex ratio (70% women), mean age (71.5 years), blood pressure (182/101 mm Hg), and proportion of patients with cardiovascular complications (35%). MEASUREMENTS AND MAIN RESULTS--In the placebo group total mortality rose with increasing systolic pressure whereas it had a U shaped relation with diastolic pressure, the total lowest mortality being in patients in the middle third of the distribution of diastolic pressure. In the group given active treatment total mortality showed a U shaped relation with systolic pressure and an inverse association with treated diastolic pressure. In both groups cardiovascular and non-cardiovascular mortality followed the same trends as total mortality. The increased mortality in the lowest thirds of pressure was not associated with an increased proportion of patients with cardiovascular complications at randomisation or with a fall in diastolic pressure exceeding the median fall in pressure in each group. In contrast, patients in the lowest thirds of pressure showed greater decreases in body weight and haemoglobin concentration than those in the middle and upper thirds of pressure. CONCLUSIONS--In patients taking active treatment total mortality was increased in the lowest thirds of treated systolic and diastolic blood pressures. This increased mortality is not necessarily explained by an exaggerated reduction in pressure induced by drugs as for diastolic pressure a U shaped relation also existed during treatment with placebo. In addition, patients in the lowest thirds of systolic and diastolic pressures were characterised by decreases in body weight and haemoglobin concentration, and the patients in the lowest thirds of diastolic pressure taking active treatment also by an increased non-cardiovascular mortality, suggesting some deterioration of general health.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

This article has been cited by other articles:

• Messerli, F. H., Panjrath, G. S. (2009). The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?. J Am Coll Cardiol 54: 1827-1834 [Abstract] [Full text]  
• Bangalore, S., Messerli, F. H., Franklin, S. S., Mancia, G., Champion, A., Pepine, C. J. (2009). Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis. Eur Heart J 30: 1395-1401 [Abstract] [Full text]  
• Fagard, R. H., Staessen, J. A., Thijs, L., Celis, H., Bulpitt, C. J., de Leeuw, P. W., Leonetti, G., Tuomilehto, J., Yodfat, Y. (2007). On-Treatment Diastolic Blood Pressure and Prognosis in Systolic Hypertension. Arch Intern Med 167: 1884-1891 [Abstract] [Full text]  
• Authors/Task Force Members:, , Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., Narkiewicz, K., Ruilope, L., Rynkiewicz, A., Schmieder, R. E., Struijker Boudier, H. A.J., Zanchetti, A., ESC Committee for Practice Guidelines (CPG):, , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., ESH Scientific Council:, , Kjeldsen, S. E., Erdine, S., Narkiewicz, K., Kiowski, W., Agabiti-Rosei, E., Ambrosioni, E., Cifkova, R., Dominiczak, A., Fagard, R., Heagerty, A. M., Laurent, S., Lindholm, L. H., Mancia, G., Manolis, A., Nilsson, P. M., Redon, J., Schmieder, R. E., Struijker-Boudier, H. A.J., Viigimaa, M., Document Reviewers:, , Filippatos, G., Adamopoulos, S., Agabiti-Rosei, E., Ambrosioni, E., Bertomeu, V., Clement, D., Erdine, S., Farsang, C., Gaita, D., Kiowski, W., Lip, G., Mallion, J.-M., Manolis, A. J., Nilsson, P. M., O'Brien, E., Ponikowski, P., Redon, J., Ruschitzka, F., Tamargo, J., van Zwieten, P., Viigimaa, M., Waeber, B., Williams, B., Zamorano, J. L. (2007). 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 0: ehm236v1-75 [Full text]  
• Kikuya, M., Ohkubo, T., Asayama, K., Metoki, H., Obara, T., Saito, S., Hashimoto, J., Totsune, K., Hoshi, H., Satoh, H., Imai, Y. (2005). Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular Mortality: The Ohasama Study. Hypertension 45: 240-245 [Abstract] [Full text]  
• Houben, M. P. W. A., Louwman, W. J., Tijssen, C. C., Teepen, J. L. J. M., van Duijn, C. M., Coebergh, J. W. W. (2004). Hypertension as a risk factor for glioma? Evidence from a population-based study of comorbidity in glioma patients. Ann Oncol 15: 1256-1260 [Abstract] [Full text]  
• Boutitie, F., Gueyffier, F., Pocock, S., Fagard, R., Boissel, J. P., for the INDANA Project Steering Committee, (2002). J-Shaped Relationship between Blood Pressure and Mortality in Hypertensive Patients: New Insights from a Meta-Analysis of Individual-Patient Data. ANN INTERN MED 136: 438-448 [Abstract] [Full text]  
• Grossman, E, Messerli, F.H, Goldbourt, U (2001). Antihypertensive therapy and the risk of malignancies. Eur Heart J 22: 1343-1352 [Abstract]  
• (1997). The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 157: 2413-2446 [Abstract]  
• McCloskey, L. W., Psaty, B. M., Koepsell, T. D., Aagaard, G. N. (1992). Level of Blood Pressure and Risk of Myocardial Infarction Among Treated Hypertensive Patients. Arch Intern Med 152: 513-520 [Abstract]  
• Gurwitz, J. H., Avorn, J. (1991). The Ambiguous Relation between Aging and Adverse Drug Reactions. ANN INTERN MED 114: 956-966 [Abstract]  
• Farnett, L., Mulrow, C. D., Linn, W. D., Lucey, C. R., Tuley, M. R. (1991). The J-Curve Phenomenon and the Treatment of Hypertension: Is There a Point Beyond Which Pressure Reduction Is Dangerous?. JAMA 265: 489-495 [Abstract]  

Online poll

Find out more here>> and here>>